MitoQ supplement for early psychosis
Part of Mental health clinical trials.
This study tests whether a supplement called MitoQ can help people with early-stage psychosis by improving how their cells produce energy. If you are younger and have been treated for psychosis for less than 5 years, this trial may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 35 years old.
- You have been diagnosed with schizophrenia, schizoaffective disorder, or a related psychosis.
- You have been treated for psychosis for less than 5 years.
- You are not currently dependent on alcohol or drugs (except tobacco or mild/moderate cannabis use).
- You have not taken antioxidant supplements (like fish oil, vitamin E, or vitamin C) in the last 14 days.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement called MitoQ can improve blood vessel health, walking speed, and thinking skills in older adults who are frail or have mild memory problems. It aims to see if MitoQ helps maintain independence and quality of life.
This trial tests whether a dietary supplement called PQQ (pyrroloquinoline quinone) can improve thinking, memory, and negative symptoms (like lack of motivation) in chronic schizophrenia. It might help because PQQ has antioxidant and anti-inflammatory effects that could protect brain health.
This trial tests whether a supplement called MitoQ improves blood vessel function in pregnant people with preeclampsia. It may help manage blood pressure and reduce complications.
This Phase 2 trial tests whether a “synbiotic” supplement (a mix of probiotics and prebiotics) can reduce symptoms of schizophrenia or schizoaffective disorder. It may help by targeting gut-related immune and inflammation pathways that could affect brain symptoms.
This study tests whether a cognitive training program can help young adults with recent psychosis improve their thinking and memory skills. It involves brain scans and cognitive exercises.
This study tests whether MitoQ, a dietary supplement that helps cells produce energy, can improve weight loss and appetite in people with cancer. It may also help slow down the muscle loss that often comes with cancer, so you can feel stronger and have a better quality of life.
Hear when a new Schizophrenia and Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.